Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery

NCT00513292 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

280

Enrollment

NIH

Sponsor class

Conditions

HER2/Neu Positive
Stage IA Breast Cancer
Stage IB Breast Cancer
Stage II Breast Cancer
Stage IIIA Breast Cancer

Interventions

DRUG: Cyclophosphamide
DRUG: Epirubicin Hydrochloride
OTHER: Laboratory Biomarker Analysis
DRUG: Paclitaxel
PROCEDURE: Therapeutic Conventional Surgery
BIOLOGICAL: Trastuzumab

Sponsor

National Cancer Institute (NCI)